Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

0.7222
Delayed Data
As of May 24
 -0.0136 / -1.85%
Today’s Change
0.65
Today|||52-Week Range
5.98
-65.61%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.74
Today’s open0.75
Day’s range0.71 - 0.75
Volume107,080
Average volume (3 months)320,825
Market cap$22.8M
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)-13.22%
Earnings growth (this year)+24.09%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+21.82%
P/E ratioNM
Price/Sales166.87
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc-0.07-6.67%
ONCSOncoSec Medical Inc+0.08+9.24%
TROVUTrovagene Inc+0.04+2.65%
--BARD1 Life Sciences ...-0.00-25.00%
Data as of 05/24/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$381.1K
Annual profit (last year)-$39.2M
Net profit margin-10,287.75%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Bill Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts